Mascitelli Luca, Goldstein Mark R, Pezzetta Francesca
Medical Service, Comando Brigata Alpina Julia, Udine, Italy.
J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):657-8. doi: 10.2459/JCM.0b013e32832c1674.
This article comments on the point of view by Rosano et al. and outlines that the only indications for hormone replacement therapy, at the lowest effective dose for the shortest possible time, should be limited to younger, recently menopausal women who are not at high risk for cardiovascular disease and with unsustainable menopausal symptoms, without any illusory attempt to prevent chronic diseases.
本文对罗萨诺等人的观点进行了评论，并概述了激素替代疗法的唯一指征，即以最低有效剂量在尽可能短的时间内，应仅限于年轻的、近期绝经且无心血管疾病高风险、有难以忍受的绝经症状的女性，而不应有任何预防慢性病的虚幻尝试。
